Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 3 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of HELZ2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2201.51 | 1445 / 1445 | 100% | 59.63 | 183 / 183 |
intestine | 100% | 2283.67 | 966 / 966 | 99% | 31.59 | 523 / 527 |
stomach | 100% | 2509.35 | 359 / 359 | 99% | 38.29 | 282 / 286 |
ovary | 100% | 1629.79 | 180 / 180 | 94% | 27.64 | 406 / 430 |
prostate | 100% | 2030.22 | 245 / 245 | 94% | 16.36 | 473 / 502 |
pancreas | 97% | 1449.04 | 318 / 328 | 97% | 21.15 | 173 / 178 |
uterus | 100% | 1907.46 | 170 / 170 | 94% | 20.75 | 432 / 459 |
breast | 100% | 2533.13 | 459 / 459 | 94% | 21.52 | 1051 / 1118 |
bladder | 100% | 1663.52 | 21 / 21 | 93% | 21.95 | 470 / 504 |
skin | 100% | 2099.48 | 1808 / 1809 | 93% | 23.74 | 440 / 472 |
lung | 100% | 4245.74 | 578 / 578 | 92% | 21.34 | 1065 / 1155 |
thymus | 100% | 2736.82 | 653 / 653 | 91% | 11.78 | 552 / 605 |
kidney | 99% | 2082.44 | 88 / 89 | 82% | 10.18 | 743 / 901 |
liver | 100% | 1690.77 | 225 / 226 | 74% | 9.30 | 301 / 406 |
adrenal gland | 100% | 1702.90 | 258 / 258 | 70% | 9.09 | 160 / 230 |
brain | 56% | 517.41 | 1486 / 2642 | 67% | 8.56 | 472 / 705 |
adipose | 100% | 2565.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 5062.66 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 1571.79 | 855 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 21.52 | 79 / 80 |
peripheral blood | 99% | 5088.37 | 917 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 25.92 | 44 / 45 |
blood vessel | 92% | 1127.11 | 1224 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 13.10 | 24 / 29 |
muscle | 36% | 230.03 | 289 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035194 | Biological process | regulatory ncRNA-mediated post-transcriptional gene silencing |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0043186 | Cellular component | P granule |
GO_0005737 | Cellular component | cytoplasm |
GO_0003677 | Molecular function | DNA binding |
GO_0008859 | Molecular function | exoribonuclease II activity |
GO_0005524 | Molecular function | ATP binding |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | HELZ2 |
Protein name | 3'-5' exoribonuclease HELZ2 (EC 3.1.13.1) (ATP-dependent RNA helicase PRIC285) (EC 3.6.4.13) (Helicase with zinc finger 2, transcriptional coactivator) (Helicase with zinc finger domain 2) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) |
Synonyms | PRIC285 KIAA1769 |
Description | FUNCTION: Can degrade highly structured RNAs through its concerted ATP-dependent RNA helicase and 3' to 5' exoribonuclease activities . Shows a strong preference for pyrimidine over purine residues for its nuclease activity . Acts as a transcriptional coactivator for a number of nuclear receptors including PPARA, PPARG, THRA, THRB and RXRA . . |
Accessions | ENST00000427522.6 [Q9BYK8-2] Q9BYK8 |